ZA898017B - Treatment of hypertension - Google Patents

Treatment of hypertension

Info

Publication number
ZA898017B
ZA898017B ZA898017A ZA898017A ZA898017B ZA 898017 B ZA898017 B ZA 898017B ZA 898017 A ZA898017 A ZA 898017A ZA 898017 A ZA898017 A ZA 898017A ZA 898017 B ZA898017 B ZA 898017B
Authority
ZA
South Africa
Prior art keywords
potassium
preferred
hypertension
treatment
methods
Prior art date
Application number
ZA898017A
Other languages
English (en)
Inventor
R Curtis Morris Jr
Curtis Morris R Jr
Anthony Sebastian
Sebastian Anthony
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of ZA898017B publication Critical patent/ZA898017B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA898017A 1988-10-21 1989-10-23 Treatment of hypertension ZA898017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21

Publications (1)

Publication Number Publication Date
ZA898017B true ZA898017B (en) 1990-12-28

Family

ID=22990921

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA898017A ZA898017B (en) 1988-10-21 1989-10-23 Treatment of hypertension
ZA898018A ZA898018B (en) 1988-10-21 1989-10-23 Treatment of osteoporosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA898018A ZA898018B (en) 1988-10-21 1989-10-23 Treatment of osteoporosis

Country Status (13)

Country Link
US (1) US5804204A (ja)
EP (3) EP0461111B1 (ja)
JP (2) JP2843146B2 (ja)
KR (2) KR0163583B1 (ja)
AT (1) ATE145825T1 (ja)
AU (2) AU635231B2 (ja)
CA (2) CA2001124C (ja)
DE (2) DE68913311T2 (ja)
DK (2) DK175840B1 (ja)
HU (2) HU212106B (ja)
IL (2) IL92076A (ja)
WO (2) WO1990004402A1 (ja)
ZA (2) ZA898017B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
JP2005529871A (ja) * 2002-04-05 2005-10-06 ビーティージー・インターナショナル・リミテッド 高血圧症の予防および治療のための低用量カリウム補充
EP1350515A1 (en) * 2002-04-05 2003-10-08 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
CN101998833A (zh) * 2008-02-06 2011-03-30 金宝汤公司 用于减少食物制品中钠含量的方法和组合物
US20110195172A1 (en) * 2008-09-05 2011-08-11 Inge Elisabeth Maria Deutz Beverages comprising potassium
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
DK72691A (da) 1991-04-22
AU634988B2 (en) 1993-03-11
CA2001123C (en) 2000-01-18
EP0440738B1 (en) 1996-12-04
IL92075A0 (en) 1990-07-12
HU208923B (en) 1994-02-28
EP0440738A4 (en) 1991-08-28
WO1990004402A1 (en) 1990-05-03
DK72791A (da) 1991-05-14
WO1990004403A1 (en) 1990-05-03
HUT63058A (en) 1993-07-28
EP0461111A1 (en) 1991-12-18
DE68927519T2 (de) 1997-04-03
JPH04501724A (ja) 1992-03-26
KR0178033B1 (ko) 1999-03-20
US5804204A (en) 1998-09-08
KR0163583B1 (ko) 1998-12-01
JPH04501419A (ja) 1992-03-12
AU4515489A (en) 1990-05-14
EP0720855A3 (en) 1998-07-08
CA2001124C (en) 2000-01-18
AU4622089A (en) 1990-05-14
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
AU635231B2 (en) 1993-03-18
DE68927519D1 (de) 1997-01-16
DK175841B1 (da) 2005-03-29
HUT57989A (en) 1992-01-28
ZA898018B (en) 1990-12-28
EP0461111B1 (en) 1994-02-23
ATE145825T1 (de) 1996-12-15
KR900701288A (ko) 1990-12-01
EP0440738A1 (en) 1991-08-14
IL92075A (en) 1995-07-31
IL92076A (en) 1995-08-31
EP0720855A2 (en) 1996-07-10
DE68913311T2 (de) 1994-05-26
HU212106B (en) 1996-02-28
JP2948247B2 (ja) 1999-09-13
IL92076A0 (en) 1990-07-12
DK72791D0 (da) 1991-04-19
DK72691D0 (da) 1991-04-19
JP2843146B2 (ja) 1999-01-06
EP0461111A4 (en) 1991-07-25
KR900701287A (ko) 1990-12-01
CA2001124A1 (en) 1990-04-21
CA2001123A1 (en) 1990-04-21
DE68913311D1 (de) 1994-03-31
DK175840B1 (da) 2005-03-29

Similar Documents

Publication Publication Date Title
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
EP0787802A3 (ja)
PL319370A1 (en) Application of photodynamic therapy for selectively inactivating blood cells and treatment o diseases associated with immunological disturbances
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
HU896567D0 (en) Treatment of hypertension
ZA914135B (en) Method of treating impotence
GR3037031T3 (en) Dermatological preparation and method for treating actinic keratoses
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
GR3000751T3 (en) Tpa-containing medical composition and use thereof
IL82317A0 (en) 1,4 dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum
Kancler et al. Tooth foci and uveitis.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
RU93032381A (ru) Способ лечения хронического описторхоза
ES8401719A1 (es) "procedimiento para mejorar la vision".
BG51278A1 (en) Method for potentiation of the therapeutical effect of human recombination erythropoietin
UA30125A (uk) Спосіб лікування дітей з ревматоїдним артритом та дифузними хворобами сполучної тканини
GEP19991514B (en) Method for Treatment with Interferon
MY117556A (en) Methods and formulations for modulating the human sexual response
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein